Peter Slavin has been a visionary leader for MGH and a tremendous ally to the biomedical research community.

After his 18 years of humble leadership and a career of service, our initial disappointment quickly fades to gratitude. We wish him well and hope to build on his legacy.

The Boston Globe@BostonGlobe

Peter Slavin, president of Massachusetts General Hospital, plans to retire after 18 years leading the prestigious institution http://bos.gl/e1UgVKp

We are seeking a stellar Genomics & Technology Core Manager in the @CGM_MGH @MGH_RI. Manager will engage in extensive technology development, personnel and project management, and interactions across the @CGM_MGH @harvardmed @broadinstitute communities. http://go.nature.com/30joPfL

It’s rare disease day! I’m living with X-linked hypophosphatemia, XLH affects the bones, muscles and teeth due to excessive phosphate wasting. I’ve had seven surgeries to help correct the affects of my disease. Here’s me recovering from my very first surgery at the age of 4. 🦓🦓

The scientific community just collectively exhaled - @JoeBiden approach:

-Ask 5 big questions
https://buildbackbetter.gov/wp-content/uploads/2021/01/OSTP-Appointment.pdf

-Find a leader @eric_lander @broadinstitute

-Assemble a stellar team @maria_zuber @NIHDirector et al.

-Provide structural support (cabinet)

-Solve problems

Load More...